Sigma Planning Corp Teva Pharmaceutical Industries LTD Transaction History

Sigma Planning Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$6.86 - $11.95 $92,493 - $161,121	13,483 New	13,483 $109,000
Q4 2021 Feb 02, 2022	SELL	$7.9 - $10.19 $79,339 - $102,338	-10,043 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$8.38 - $10.18 $84,160 - $102,237	10,043 New	10,043 $98,000
Q4 2018 Jan 31, 2019	SELL	$14.59 - $23.84 $144,382 - $235,920	-9,896 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$21.06 - $25.65 $21,060 - $25,650	-1,000 Reduced 9.18%	9,896 $213,000
Q2 2018 Aug 02, 2018	SELL	$16.77 - $24.71 $41,019 - $60,440	-2,446 Reduced 18.33%	10,896 $265,000
Q1 2018 May 11, 2018	BUY	$16.68 - $22.07 $33,977 - $44,956	2,037 Added 18.02%	13,342 $228,000
Q4 2017 Feb 07, 2018	BUY	$11.23 - $19.1 $126,955 - $215,925	11,305	11,305 $214,000

603

567M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.